Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McElrath

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Pageof 2